First Time Loading...

InflaRx NV
NASDAQ:IFRX

Watchlist Manager
InflaRx NV Logo
InflaRx NV
NASDAQ:IFRX
Watchlist
Price: 1.295 USD -6.16%
Updated: May 7, 2024

Wall Street
Price Targets

IFRX Price Targets Summary
InflaRx NV

Wall Street analysts forecast IFRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IFRX is 8.16 USD with a low forecast of 5.05 USD and a high forecast of 12.6 USD.

Lowest
Price Target
5.05 USD
290% Upside
Average
Price Target
8.16 USD
530% Upside
Highest
Price Target
12.6 USD
873% Upside
InflaRx NV Competitors:
Price Targets
RNA
Avidity Biosciences Inc
85% Upside
688266
Suzhou Zelgen Biopharmaceuticals Co Ltd
6% Upside
ALLK
Allakos Inc
153% Upside
RYTM
Rhythm Pharmaceuticals Inc
37% Upside
MDG1
Medigene AG
74% Upside
9966
Alphamab Oncology
66% Upside
084650
Labgenomics Co Ltd
90% Upside
BIOA B
BioArctic AB
88% Upside

Revenue
Forecast

Revenue Estimate
InflaRx NV

The compound annual growth rate of InflaRx NV's revenue for the next 3 years is 747%.

N/A
Past Growth
747%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
InflaRx NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
InflaRx NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-50%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IFRX's stock price target?
Price Target
8.16 USD

According to Wall Street analysts, the average 1-year price target for IFRX is 8.16 USD with a low forecast of 5.05 USD and a high forecast of 12.6 USD.

What is InflaRx NV's Revenue forecast?
Projected CAGR
747%

The compound annual growth rate of InflaRx NV's revenue for the next 3 years is 747%.